Aurinia Pharmaceuticals Inc Share Price
NASDAQ: AUPHHealthcare
Live Aurinia Pharmaceuticals Inc Share Price Chart
O H L
Aurinia Pharmaceuticals Inc Performance Overview
Days Range
▼
$16.80Low
$17.02High
Markets Today
| Previous Close | $16.96 |
|---|---|
| Open | $16.80 |
| Volume | 108,848 |
| Day's Range | $16.80 - $17.02 |
| 52W Range | $10.34 - $19.25 |
| Market Cap | $2.26 B |
Historical Performance
| 1M Returns | +10.85 |
|---|---|
| 3M Returns | +3.04 |
| 6M Returns | +20.45 |
| 1Y Returns | +31.57 |
| 5Y Returns | -19.24 |
| 10Y Returns | +719.32 |
Aurinia Pharmaceuticals Inc Fundamentals
| Market Cap | $2.26 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 7.41 |
| PEG Ratio | N/A |
| Revenue | $283.06 M |
| ROE TTM | 0.60 |
| EPS TTM | $2.29 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.67 |
| EBITDA | $126.01 M |
| Profit Margin | 101.47 |
| Market Cap | $2.26 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 7.41 |
| PEG Ratio | N/A |
| Revenue | $283.06 M |
| ROE TTM | 0.60 |
| EPS TTM | $2.29 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.67 |
| EBITDA | $126.01 M |
| Profit Margin | 101.47 |
Aurinia Pharmaceuticals Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $62.47 M | $70.01 M | $73.47 M | $77.11 M | $77.70 M | $83.22 M |
| Gross Profit + | $53.89 M | $62.89 M | $65.29 M | $68.31 M | $71.20 M | $76.67 M |
| Operating Income | $21.85 M | $20.08 M | $30.67 M | $18.64 M | $41.42 M | $46.34 M |
| EBITDA | $28.24 M | $25.06 M | $35.54 M | $23.50 M | $46.24 M | $51.17 M |
| Interest Expense | -$1.07 M | -$1.12 M | -$1.10 M | -$1.05 M | -$1.01 M | -$948.00 K |
| Depreciation | $6.39 M | $4.98 M | $4.87 M | $4.86 M | $4.82 M | $4.83 M |
| Income Before Tax | $24.35 M | $22.16 M | $31.96 M | $35.69 M | $43.92 M | $48.79 M |
| Income Tax Expense | $1.00 M | $643.00 K | $411.00 K | -$175.10 M | $9.57 M | $11.37 M |
| Net Income + | $23.34 M | $21.51 M | $31.55 M | $210.79 M | $34.35 M | $37.41 M |
| Net Profit Margin | 37.37% | 30.73% | 42.95% | 273.35% | 44.21% | 44.96% |
Aurinia Pharmaceuticals Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.16 B | $1.12 B | $1.12 B | $1.12 B | $1.09 B | $1.12 B |
| Reserve & Surplus | -$914.05 M | -$892.62 M | -$860.91 M | -$649.97 M | -$615.89 M | -$578.58 M |
| Non-Current Liabilities | $86.25 M | $89.00 M | $85.54 M | $76.53 M | $69.81 M | $77.50 M |
| Current Liabilities | $68.41 M | $78.27 M | $76.22 M | $93.72 M | $86.56 M | $99.89 M |
| Total Liabilities | $154.66 M | $167.26 M | $161.76 M | $170.26 M | $156.37 M | $177.40 M |
| Fixed Assets | $6.73 M | $6.47 M | $6.17 M | $5.87 M | $5.58 M | $5.24 M |
| Current Assets | $405.76 M | $408.97 M | $438.74 M | $491.97 M | $480.24 M | $541.32 M |
| Total Assets | $504.85 M | $502.56 M | $527.53 M | $751.59 M | $724.00 M | $792.26 M |
Aurinia Pharmaceuticals Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $23.34 M | $21.51 M | $31.55 M | $210.79 M | $34.35 M | $37.41 M |
| Operating Cash Flow | $1.30 M | $44.24 M | $44.45 M | $45.67 M | $32.56 M | $52.57 M |
| Investing Cash Flow | $31.03 M | -$13.27 M | -$13.77 M | -$36.76 M | -$18.08 M | $81.45 M |
| Financing Cash Flow | -$49.34 M | -$44.39 M | -$10.49 M | -$1.89 M | -$53.69 M | $4.81 M |
| Change in Cash | -$17.00 M | -$13.43 M | $20.19 M | $7.02 M | -$39.20 M | $138.82 M |
Aurinia Pharmaceuticals Inc Return Calculator
The Aurinia Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$8,019
Invested Amount$10,000
Est. Returns$-1,981
About Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Popular Stocks
FAQs
What is the share price of Aurinia Pharmaceuticals Inc today?
Aurinia Pharmaceuticals Inc (AUPH) share price as of September 18, 2026 is $16.84. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Aurinia Pharmaceuticals Inc?
Yes, Indian Investors can invest in the Aurinia Pharmaceuticals Inc (AUPH) Share by opening an international trading account with Angel One.
How can I purchase Aurinia Pharmaceuticals Inc shares in India?
Purchasing Aurinia Pharmaceuticals Inc (AUPH) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Aurinia Pharmaceuticals Inc (AUPH) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Aurinia Pharmaceuticals Inc?
Yes, you can purchase fractional shares of Aurinia Pharmaceuticals Inc (AUPH) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Aurinia Pharmaceuticals Inc?
The market capitalization of Aurinia Pharmaceuticals Inc on September 18, 2026, is $2.26 B.
In which sector Aurinia Pharmaceuticals Inc belongs?
Aurinia Pharmaceuticals Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Aurinia Pharmaceuticals Inc stocks?
In order to invest in Aurinia Pharmaceuticals Inc (AUPH) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
